RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease
Condition: Crohn Disease Intervention: Drug: RVT-3101 Sponsor: Telavant, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials